Literature DB >> 16563964

Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device.

Timothy J Myers1, O H Frazier, Hernando S Mesina, Branislav Radovancevic, Igor D Gregoric.   

Abstract

BACKGROUND: Axial-flow left ventricular assist devices (LVADs), when inactivated, may result in regurgitant blood flow. We assessed the effects of regurgitant pump flow with the intraventricular Jarvik 2000 Heart LVAD (Jarvik Heart, Inc., New York, NY) on hemodynamics and patient safety under pump-off conditions.
METHODS: Thirty patients being supported by a Jarvik 2000 as a bridge to heart transplantation underwent pump-off studies. Hemodynamics, vital signs and cognitive function were monitored; Doppler echocardiographic studies were done with the pump turned off for 5 minutes if tolerated. Regurgitant flow was assessed in terms of the difference between left ventricular and right ventricular outflow tract cardiac output (LVOT CO - RVOT CO).
RESULTS: During pump-off periods, the mean regurgitant flow was 0.42 +/- 0.41 liter/min, and the mean arterial blood pressure was 63.1 +/- 11.6 mm Hg. There was no regurgitant flow when the pump was on. Three patients did not tolerate the pump being off for periods of 5 minutes; in these tests, the mean regurgitant flow rate was 0.54 +/- 0.50 liter/min, the mean arterial blood pressure was 52.8 +/- 9.8 mm Hg, and the mean pump-off time was 3.1 +/- 1.1 minutes. All patients remained conscious during the pump-off period, and none showed lasting adverse effects.
CONCLUSIONS: Our findings suggest that patients being supported with the axial-flow Jarvik 2000 Heart LVAD can generally tolerate pump-off times of 5 minutes.

Entities:  

Mesh:

Year:  2006        PMID: 16563964     DOI: 10.1016/j.healun.2005.11.459

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  10 in total

1.  In vivo evaluation of the HeartWare centrifugal ventricular assist device.

Authors:  Egemen Tuzun; Katy Roberts; William E Cohn; Murat Sargin; Courtney J Gemmato; Branislav Radovancevic; O H Frazier
Journal:  Tex Heart Inst J       Date:  2007

Review 2.  Management of aortic insufficiency in the continuous flow left ventricular assist device population.

Authors:  Jonathan Holtz; Jeffrey Teuteberg
Journal:  Curr Heart Fail Rep       Date:  2014-03

3.  What is the ideal off-test trial for continuous-flow ventricular-assist-device explantation? Intracircuit back-flow analysis in a mock circulation model.

Authors:  Masahiko Ando; Takashi Nishimura; Yoshiaki Takewa; Daisuke Ogawa; Kenji Yamazaki; Koichi Kashiwa; Shunei Kyo; Minoru Ono; Yoshiyuki Taenaka; Eisuke Tatsumi
Journal:  J Artif Organs       Date:  2011-01-18       Impact factor: 1.731

4.  A novel counterpulse drive mode of continuous-flow left ventricular assist devices can minimize intracircuit backward flow during pump weaning.

Authors:  Masahiko Ando; Takashi Nishimura; Yoshiaki Takewa; Daisuke Ogawa; Kenji Yamazaki; Koichi Kashiwa; Shunei Kyo; Minoru Ono; Yoshiyuki Taenaka; Eisuke Tatsumi
Journal:  J Artif Organs       Date:  2011-01-18       Impact factor: 1.731

5.  Hemodynamic changes during left ventricular assist device-off test correlate with the degree of cardiac fibrosis and predict the outcome after device explantation.

Authors:  Shunsuke Saito; Koichi Toda; Shigeru Miyagawa; Yasushi Yoshikawa; Satsuki Fukushima; Yasushi Sakata; Isamu Mizote; Takashi Daimon; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2014-11-05       Impact factor: 1.731

6.  Successful weaning from the DuraHeart with a low left ventricular ejection fraction.

Authors:  Mitsutoshi Kimura; Osamu Kinoshita; Takashi Nishimura; Teruhiko Imamura; Taro Shiga; Koichi Kashiwa; Koichiro Kinugawa; Shunei Kyo; Minoru Ono
Journal:  J Artif Organs       Date:  2013-08-02       Impact factor: 1.731

7.  Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device.

Authors:  Deepak K Gupta; Hicham Skali; Jose Rivero; Patricia Campbell; Leslie Griffin; Colleen Smith; Courtney Foster; Brian Claggett; Robert J Glynn; Gregory Couper; Michael M Givertz; Mandeep R Mehra; Marcelo Di Carli; Scott D Solomon; Marc A Pfeffer
Journal:  J Heart Lung Transplant       Date:  2014-01-27       Impact factor: 10.247

Review 8.  Expanding the Scope of Multimodality Imaging in Durable Mechanical Circulatory Support.

Authors:  Zaid I Almarzooq; Anubodh S Varshney; Muthiah Vaduganathan; Manan Pareek; Garrick C Stewart; Jerry D Estep; Mandeep R Mehra
Journal:  JACC Cardiovasc Imaging       Date:  2019-09-18

9.  Novel echocardiographic parameters of aortic insufficiency in continuous-flow left ventricular assist devices and clinical outcome.

Authors:  Jonathan Grinstein; Eric Kruse; Gabriel Sayer; Savitri Fedson; Gene H Kim; Nitasha Sarswat; Sirtaz Adatya; Takeyoshi Ota; Valluvan Jeevanandam; Victor Mor-Avi; Roberto M Lang; Nir Uriel
Journal:  J Heart Lung Transplant       Date:  2016-05-20       Impact factor: 10.247

10.  Ultrasound-based estimation of remaining cardiac function in LVAD-supported ex vivo hearts.

Authors:  Louis S Fixsen; Niels J Petterson; Patrick Houthuizen; Marcel C M Rutten; Frans N van de Vosse; Richard G P Lopata
Journal:  Artif Organs       Date:  2020-04-18       Impact factor: 3.094

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.